X-linked inhibitor of apoptosis
Última atualização 18 de ago de 2020
Atende aos diretrizes editoriais
- BaixarBaixar
- Compartilhar
- Language
- Discussão
- Ask Patient
- Versão em Áudio
- Adicionar às fontes preferidas no Google
A XIAP gene provides instructions for making a protein that is found in many types of cells, including immune cells. It helps protect these cells from self-destructing (undergoing apoptosis) by blocking (inhibiting) the action of certain enzymes called caspases, which are necessary for apoptosis. Specifically, the XIAP protein inhibits caspase enzymes 3, 7, and 9. The XIAP protein also plays a role in several other signaling pathways that are involved in various functions in the body.
Escolhas de vídeos para GenesBiblioteca de vídeos
Normal function
A XIAP gene provides instructions for making a protein that is found in many types of cells, including immune cells. It helps protect these cells from self-destructing (undergoing apoptosis) by blocking (inhibiting) the action of certain enzymes called caspases, which are necessary for apoptosis. Specifically, the XIAP protein inhibits caspase enzymes 3, 7, and 9. The XIAP protein also plays a role in several other signaling pathways that are involved in various functions in the body.
Conditions referring to this gene or chromosome
Other names
API3
apoptosis inhibitor 3
baculoviral IAP repeat-containing protein 4
BIRC4
hILP
IAP-like protein, human
mammalian IAP homolog A
MIHA
X-linked inhibitor of apoptosis protein
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
XIAP_HUMAN
Related patient information and medicines

Patient information leaflet
Distrofia muscular de Duchenne
The muscle weakness is mainly in the 'proximal' muscles, which are those near the trunk of the body, around the hips and the shoulders. Medicamentos called ACE inhibitors ACE inhibitors are recommended which slow down the progression of the disease and also prevent damage to heart muscle. Gene therapy The National Institute for Health and Care.

Patient information leaflet
Doença renal diabética
Tratamento aims to prevent or delay the progression of the doença. Also, it aims to reduce the risk of developing cardiovascular diseases such as heart attack and stroke which are much more common than average in people with this disease. Diabetic kidney disease is one of the causes of chronic kidney disease Chronic kidney disease , a long-term.

Patient information leaflet
Esclerose sistêmica
Esclerose sistêmica is a type of scleroderma, which means hard skin. If you have scleroderma, you have areas of hardening of the skin. In systemic sclerosis, you can also get hardening of some of your internal organs. The... What is systemic sclerosis. Esclerose sistêmica é um autoimmune disease. This means that the immune system causes damage to.

Patient information leaflet
Doença de Parkinson
The main sintomas de Doença de Parkinson are usually stiffness, shaking (tremor), and slowness of movement. Treatment often provides good relief of symptoms for several years. Doença de Parkinson is a progressive neurological degeneration of certain cells (called dopaminergic cells) within a specific part of the brain (substantia nigra). The.

Patient information leaflet
Hemofilia
Hemofilia is a rare bleeding disorder that affects your ability to make a clot. When you injure yourself the clot stops you bleeding. Haemophilia is a condition where there is a deficiency of clotting factors, so people with this condition usually have prolonged bleeding. There is no cure but with available treatments most people with.

Patient information leaflet
Posso tomar Esomeprazol e Ezetimiba juntos?
Existem no known significant interactions between esomeprazole and ezetimibe. Por que isso acontece Esomeprazole (a proton pump inhibitor) and ezetimibe (a cholesterol absorption inhibitor) work through different pathways in the body and do not significantly interfere with each other's absorption, metabolism, or excretion. What you should do You can.
Leitura adicional e referências
- X-linked inhibitor of apoptosis; MedlinePlus, National Library of Medicine.
- Holcik M, Gibson H, Korneluk RG. XIAP: apoptotic brake and promising therapeutic target. Apoptosis. 2001 Aug;6(4):253-61. doi: 10.1023/a:1011379307472.
- Latour S. Natural killer T cells and X-linked lymphoproliferative syndrome. Curr Opin Allergy Clin Immunol. 2007 Dec;7(6):510-4. doi: 10.1097/ACI.0b013e3282f1bad6.
- Marsh RA, Madden L, Kitchen BJ, Mody R, McClimon B, Jordan MB, Bleesing JJ, Zhang K, Filipovich AH. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood. 2010 Aug 19;116(7):1079-82. doi: 10.1182/blood-2010-01-256099. Epub 2010 May 20.
- Marsh RA, Villanueva J, Kim MO, Zhang K, Marmer D, Risma KA, Jordan MB, Bleesing JJ, Filipovich AH. Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations. Clin Immunol. 2009 Jul;132(1):116-23. doi: 10.1016/j.clim.2009.03.517. Epub 2009 Apr 23.
- Rigaud S, Fondaneche MC, Lambert N, Pasquier B, Mateo V, Soulas P, Galicier L, Le Deist F, Rieux-Laucat F, Revy P, Fischer A, de Saint Basile G, Latour S. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 2006 Nov 2;444(7115):110-4. doi: 10.1038/nature05257.
Compartilhe seus pensamentos ou experiências com outros em nosso comunidades de pacientes.
Inscreva-se no boletim informativo do Patient
Sua dose semanal de conselhos de saúde claros e confiáveis - escritos para ajudá-lo a se sentir informado, confiante e no controle.
Ao se inscrever, você aceita nossos Política de Privacidade. Você pode cancelar a inscrição a qualquer momento. Nunca vendemos seus dados.

